Lv21
200 积分 2023-10-11 加入
[Correlation between common driver gene variations and clinicopathological typing in lung adenocarcinoma]
3个月前
已完结
[Clinicopathological analysis of 4 cases of lung cancer with concomitant EGFR mutation and ROS1 fusion]
3个月前
已完结
Interlesional response heterogeneity is associated with the prognosis of abiraterone treatment in metastatic castration-resistant prostate cancer
4个月前
已完结
Safety, Efficacy and Biomarker Analysis of Crizotinib in MET Mutated Non-Small Cell Lung Cancer – Results from the Drug Rediscovery Protocol
4个月前
已完结
Brief Report: Osimertinib Plus Capmatinib for Patients with MET-Altered EGFR-Mutant NSCLC following progression on front line therapy
4个月前
已关闭
Molecular diagnosis of primary CNS lymphoma in 2024 using MYD88Leu265Pro and IL-10
6个月前
已完结
Poor response to selpercatinib plus crizotinib in a rearranged during transfection fusion-positive patient with acquired selpercatinib-resistant MNNG HOS transforming amplification: a case report
7个月前
已完结
Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma
8个月前
已完结
Management of Insomnia
9个月前
已完结
Co-occurring EGFR p.E709X mutation Mediates Primary Resistance to the Third-generation EGFR-TKIs in EGFR p.G719X-mutant Patients with Advanced NSCLC
1年前
已完结
皖公网安备34019202002308
